John R. Wunderlich

National Cancer Institute — United States

Immunology and Microbiology · Life Sciences

61h-index32.6kcitations267works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(147), CAR-T cell therapy research(115), Cancer Immunotherapy and Biomarkers(89), Monoclonal and Polyclonal Antibodies Research(40), Immune Cell Function and Interaction(36)

Publications265 total

Supplementary Figures from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Figures from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Data from Unique Neoantigens Arise from Somatic Mutations in Patients with Gastrointestinal Cancers
2023Open Access
Supplementary Figure 1, Supplementary Figure 2 from Identification of an Immunogenic Subset of Metastatic Uveal Melanoma
2023Open Access
Data from Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2023Open Access
Supplemental Table 2 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
2023Open Access
Supplemental Figure 2 from Characterization of an Immunogenic Mutation in a Patient with Metastatic Triple-Negative Breast Cancer
2023Open Access
Supplementary Table 2 from Human Melanoma Metastases Demonstrate Nonstochastic Site-Specific Antigen Heterogeneity That Correlates with T-cell Infiltration
2023Open Access
Data from Gene Expression Profiling using Nanostring Digital RNA Counting to Identify Potential Target Antigens for Melanoma Immunotherapy
2023Open Access
page 1 of 14Next →

Frequent Co-authors

Steven A. Rosenberg(42), Mark E. Dudley(26), Paul F. Robbins(17), Richard M. Sherry(17), Nicholas P. Restifo(15), James Chih‐Hsin Yang(14), Udai S. Kammula(13), Donald E. White(11), Marybeth S. Hughes(11), James C. Yang(10), Robert Somerville(8), Suzanne L. Topalian(6), Kathleen E. Morton(6), Carolyn M. Laurençot(6), Eric Tran(6), Yong F. Li(6), Todd D. Prickett(6), Michelle M. Langhan(6), Linda Rogers-Freezer(5), Sharon Mavroukakis(5)